Skip to main content
letter
. 2021 Jun 25;5(7):e597. doi: 10.1097/HS9.0000000000000597

Table 1.

Patient Characteristics.

Patient Characteristics (n = 335)
Median age (y; range) 65 (32–88)
Country (DE/AT/CH; n = 324) 156 (48.1%)/130 (40.1%)/38 (11.7%)
Gender (male/female; n = 333) 164 (49.2%)/169 (50.8%)
Prior lines of therapy (n = 305)
 1 70 (23.0%)
 2–3 106 (34.8%)
 ≥4 129 (42.3%)
Median time (y) since start of first-line therapy (range) 4.96 (0.04–27.97)
ASCT (yes/no; n = 325) 245 (75.4%)/80 (24.6%)
Infections During 12 mo Before Start of Therapy, n = 322 6 mo After Start of Therapy, n = 314
 None 155 (48.1%) 181 (57.6%)
 1–3 128 (39.8%) 125 (39.8%)
 ≥4 39 (12.1%) 8 (2.5%)

ASCT = autologous stem cell transplantation; AT = Austria; CH = Switzerland; DE = Germany.